177Lu-PSMA-617 Therapy in a Patient on Haemodialysis with End Stage Renal Failure

被引:0
|
作者
MacFarlane, L. [1 ]
Eifer, M. [1 ]
Saghebi, J. [1 ]
机构
[1] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OP-508
引用
收藏
页码:S248 / S248
页数:1
相关论文
共 50 条
  • [21] SNMMI Consensus Statement on Patient Selection and Appropriate Use of 177Lu-PSMA-617 Radionuclide Therapy
    Hope, Thomas A.
    Antonarakis, Emmanuel S.
    Bodei, Lisa
    Calais, Jeremie
    Iravani, Amir
    Jacene, Heather
    Koo, Phillip J.
    Morgans, Alicia K.
    Osborne, Joseph R.
    Tagawa, Scott T.
    Taplin, Mary-Ellen
    Sartor, Oliver
    Morris, Michael J.
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (09) : 1417 - 1423
  • [22] Feasibility of 177Lu-PSMA-617 radioligand therapy in a patient with recurrent high-grade glioma
    Holzgreve, A.
    Delker, A.
    Wenter, V.
    Zacherl, M. J.
    Thon, N.
    Harter, P.
    Brendel, M.
    Unterrainer, L. M.
    Niyazi, M.
    Bartenstein, P.
    von Baumgarten, L.
    Albert, N. L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S217 - S217
  • [23] 177LU-PSMA-617 PRODUCTION AND QUALITY CONTROL AT THE RAH
    Girvin, Mark
    INTERNAL MEDICINE JOURNAL, 2023, 53 : 14 - 14
  • [24] Possible Treatment Approach to an Extravasation of 177Lu-PSMA-617
    Schlenkhoff, Carl Diedrich
    Essler, Markus
    Ahmadzadehfar, Hojjat
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (08) : 639 - 640
  • [25] 177Lu-PSMA-617 for metastatic prostate cancer in India
    Ghose, Aruni
    Banerjee, Soirindhri
    Choudhury, Partha S.
    Maniam, Akash
    Gupta, Manoj
    Banna, Giuseppe L.
    Vasdev, Nikhil
    Ghose, Amit
    Noronha, Vanita
    Mitra, Swarupa
    LANCET REGIONAL HEALTH - SOUTHEAST ASIA, 2024, 30
  • [26] 177Lu-PSMA-617 radioligand therapy of mCRPC: evaluation criteria of response Reply
    Yadav, Madhav Prasad
    Ballal, Sanjana
    Tripathi, Madhavi
    Bal, Chandrasekhal
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (01) : 168 - 169
  • [27] 177Lu-PSMA-617 radioligand therapy in mCRPC: ready for phase III trial?
    Kambiz Rahbar
    Hojjat Ahmadzadehfar
    Martin Boegemann
    European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 513 - 514
  • [28] 177Lu-PSMA-617 radioligand therapy in mCRPC: ready for phase III trial?
    Rahbar, Kambiz
    Ahmadzadehfar, Hojjat
    Boegemann, Martin
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (03) : 513 - 514
  • [29] 177Lu-PSMA-617 therapy in Chemotherapy Naive patients: A single center experience
    Kulkarni, Raksha
    Abdelrahman, Ahmed
    Novello, Matteo
    Cengiz, Turgut Bora
    Akinlusi, Rahman
    Bander, Ilda
    Patel, Vaibhav
    Wise, David
    Ghesani, Munir
    Ghesani, Nasrin
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [30] First Experience With 177Lu-PSMA-617 Therapy for Advanced Prostate Cancer in the Netherlands
    van Kalmthout, Ludwike
    Braat, Arthur
    Lam, Marnix
    van Leeuwaarde, Rachel
    Krijger, Gerard
    Ververs, Tessa
    Mehra, Niven
    Bins, Adriaan
    Hunting, Jarmo
    de Keizer, Bart
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (06) : 446 - 451